---
title: "此舉令香港成為亞洲首個推行組織碎化技術（Histotripsy）腎臟癌臨床試驗的城市。 — 李嘉誠基金會 — DecisionGateway"
description: "statement by 李嘉誠基金會, recorded recently — verbatim quote and source citation."
canonical_url: "https://dgw.tmarket.io/claims/01a1e96c-97d2-7460-b264-233588f7debe"
meta:
  "og:description": "statement by 李嘉誠基金會, recorded recently — verbatim quote and source citation."
  "og:image": "https://dgw.tmarket.io/og.jpg"
  "og:image:alt": "White network of connected nodes crossed by a timeline on black"
  "og:image:height": "1024"
  "og:image:width": "1024"
  "og:title": "此舉令香港成為亞洲首個推行組織碎化技術（Histotripsy）腎臟癌臨床試驗的城市。 — 李嘉誠基金會 — DecisionGateway"
  "twitter:image": "https://dgw.tmarket.io/og.jpg"
---

> Index of every page on this site: [llms.txt](https://dgw.tmarket.io/llms.txt)

statement

# **此舉令香港成為亞洲首個推行組織碎化技術（Histotripsy）腎臟癌臨床試驗的城市。**

A statement by [**李嘉誠基金會**](https://dgw.tmarket.io/actors/01a1e96c-9779-7670-815e-9277f175374e). Statements are as reported by the cited publishers — not verified by DecisionGateway.

> *令香港成為亞洲首個推行組織碎化技術（Histotripsy）腎臟癌臨床試驗的城市*

rthk\_new\_cPublished 2026-11-11 [ Read source](https://t.me/rthk_new_c/401274)

[**李嘉誠基金會 dossier **](https://dgw.tmarket.io/actors/01a1e96c-9779-7670-815e-9277f175374e)

## **Discussion**

## **Related claims**

[**港怡醫院和香港中文大學醫院正在以組織碎化技術進行胰臟癌臨床試驗。**post author · statement](https://dgw.tmarket.io/claims/01a1e96c-97ee-7e95-a08b-78d7b30f2e7c) [**Hong Kong has launched Asia's first kidney cancer clinical trial.**headline · statement](https://dgw.tmarket.io/claims/01a1ecba-5319-740a-b41b-f0f32d29c80b) [**港怡自今年3月31日開始，已成功完成20宗胰臟腫瘤個案。**post author · statement](https://dgw.tmarket.io/claims/01a1e96c-9802-7563-9c4b-0a2374795ec8) [**渣打香港宣布完成為螞蟻國際的代幣化貨幣市場基金投資提供贖回流動性融資的試點項目。**渣打香港 · statement](https://dgw.tmarket.io/claims/01a1e731-7488-741a-ad56-e126ae6b7328) [**Chips are piling up in Hong Kong.**部分獲授權處理 H200 的公司疑為空殼，晶片又在香港堆積。 · allegation](https://dgw.tmarket.io/claims/01a1cbb9-401d-70b5-975d-851ac016a014) [**Li Ka-shing is again promoting ultrasound non-invasive cancer treatment.**headline · statement](https://dgw.tmarket.io/claims/01a1ecba-5306-7c14-8f16-8fefac1f1fd5)

## **More claims by 李嘉誠基金會**

[**過去兩年在香港已順利治療超過400名病人。**statement](https://dgw.tmarket.io/claims/01a1e96c-97de-758e-b3a7-d531367011f8) [**李嘉誠將向香港中文大學醫院、港怡醫院及養和醫院提供30個臨床試驗名額。**commitment](https://dgw.tmarket.io/claims/01a1e96c-97c1-7d94-93bc-408385aeabfd)

[All claims by 李嘉誠基金會](https://dgw.tmarket.io/claims?claimant_id=01a1e96c-9779-7670-815e-9277f175374e)

[All claims](https://dgw.tmarket.io/claims)

```json
{"@context":"https://schema.org","@graph":[{"@id":"https://dgw.tmarket.io/#website","@type":"WebSite","description":"Decisions, events and falsifiable forecasts — every claim cited to its public source. Read free.","name":"DecisionGateway","url":"https://dgw.tmarket.io/","publisher":{"@id":"https://dgw.tmarket.io/#identity"}},{"@id":"https://dgw.tmarket.io/claims/01a1e96c-97d2-7460-b264-233588f7debe#webpage","@type":"WebPage","description":"statement by 李嘉誠基金會, recorded recently — verbatim quote and source citation.","name":"此舉令香港成為亞洲首個推行組織碎化技術（Histotripsy）腎臟癌臨床試驗的城市。 — 李嘉誠基金會 — DecisionGateway","url":"https://dgw.tmarket.io/claims/01a1e96c-97d2-7460-b264-233588f7debe","breadcrumb":{"@id":"https://dgw.tmarket.io/claims/01a1e96c-97d2-7460-b264-233588f7debe#breadcrumb"},"isPartOf":{"@id":"https://dgw.tmarket.io/#website"},"potentialAction":[{"@type":"ReadAction","target":["https://dgw.tmarket.io/claims/01a1e96c-97d2-7460-b264-233588f7debe"]}]},{"@id":"https://dgw.tmarket.io/#identity","@type":"Organization","name":"DecisionGateway","url":"https://dgw.tmarket.io"},{"@id":"https://dgw.tmarket.io/claims/01a1e96c-97d2-7460-b264-233588f7debe#breadcrumb","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","name":"Home","item":"https://dgw.tmarket.io","position":1},{"@type":"ListItem","name":"Claims","item":"https://dgw.tmarket.io/claims","position":2},{"@type":"ListItem","name":"此舉令香港成為亞洲首個推行組織碎化技術（Histotripsy）腎臟癌臨床試驗的城市。","position":3}]},{"@id":"https://dgw.tmarket.io/claims/01a1e96c-97d2-7460-b264-233588f7debe#/schema/quotation/1","@type":"Quotation","dateCreated":"2026-11-11","isBasedOn":"https://t.me/rthk_new_c/401274","text":"令香港成為亞洲首個推行組織碎化技術（Histotripsy）腎臟癌臨床試驗的城市","url":"/claims/01a1e96c-97d2-7460-b264-233588f7debe","spokenByCharacter":{"@type":"Person","name":"李嘉誠基金會","@id":"/actors/01a1e96c-9779-7670-815e-9277f175374e"}}]}
```

## Sitemap

See the full [sitemap](https://dgw.tmarket.io/sitemap.md) for all pages.
